Real-world data from the UK shows patients with post-traumatic stress disorder (PTSD) experienced an improvement in symptoms and quality of life when prescribed cannabis. The new study published in the Expert Review of Neurotherapeutics found that patients enrolled on the UK Medical Cannabis Registry experienced an [...]
A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis research company, Cannabis Orchards, has signed an agreement with the National Institute of Health (NIH) to participate in the Epilepsy [...]
Demand for intoxicating hemp-derived cannabinoids (IHDCs) – which give users a legal ‘high’ – is now rising across Europe and the UK, but a lack of research and regulation could put consumers at risk. CBD could be considered the calming, non-psychoactive cousin of delta-9 THC, the [...]
Jushi Holdings is a large multi-state operator with a massive national footprint and a presence in key markets, including Pennsylvania, Illinois, Virginia, Massachusetts, Nevada, Ohio and California. About a year and a half ago, Aaron Green interviewed Andreas “Dre” Neumann, Chief Creative Director of Jushi Holdings [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
